Back to top
more

Abaxis,Inc. (ABAX)

(Real Time Quote from BATS)

$83.00 USD

83.00
NA

-0.09 (-0.11%)

Updated Jul 31, 2018 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Medical Instrument Stocks Head-to-Head: Abiomed vs. STERIS

Here we take a look at the fundamentals of Abiomed (ABMD) and STERIS (STE) to determine which stock is a better pick in the Medical Instruments space.

    Varian Medical (VAR) Launches Velocity 4.0, Shares Rise

    The introduction of Velocity 4.0 is in line with Varian Medical's (VAR) strategy to target the radiation-dosimetry market. The platform will help patients with liver malignancies.

      Will Buyouts Help Quest Diagnostics (DGX) Beat Q1 Earnings?

      Quest Diagnostics' (DGX) successful strategies to build esoteric testing business and boost profit margins raise optimism among investors on the stock.

        Here's Why You Should Hold on to Varian Medical Stock Now

        Here we take a peek at Varian Medical's (VAR) performance to analyze why investors should hold on to this stock despite adversities.

          SRDX or HAE: Which is a Better Medical Product Stock?

          Here we analyze the financials and fundamental factors of Haemonetics (HAE) and Surmodics (SRDX) to decide which is a better investment option.

            Zacks.com featured highlights include: Abaxis, Haynes International, MakeMyTrip and Vectrus

            Zacks.com featured highlights include: Abaxis, Haynes International, MakeMyTrip and Vectrus

              Tirthankar Chakraborty headshot

              4 Top Stocks to Buy With Superb Earnings Acceleration

              If the rate of a company's quarter-over-quarter earnings growth increases within a stipulated frame of time, it can be called earnings acceleration.

                Abaxis Banks on Strong Veterinary Business Amid Margin Woes

                Abaxis' (ABAX) strong performance in Veterinary consumables drives growth. Weak gross and operating margin scenario is a concern.

                  Why Is Abaxis (ABAX) Up 6.5% Since Its Last Earnings Report?

                  Abaxis (ABAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                    Abaxis (ABAX) at a 52-Week High: What's Driving the Stock?

                    Abaxis (ABAX) rides high on recently received approval from USDA.

                      Abaxis (ABAX) Beats Earnings and Revenue Estimates in Q3

                      Abaxis (ABAX) Q3 earnings gain on strength in Medical and Veterinary segments.

                        Abaxis' Product Line Expansion Aids Growth, Rivalry Rife

                        Abaxis' (ABAX) growing portfolio of rapid test menu and a strong performance in Veterinary consumables drive growth. Intense competition in both the Medical and Veterinary markets is a concern.

                          Abaxis' (ABAX) Preliminary Results for Q3 Cheer Investors

                          Abaxis (ABAX) expects substantial tax savings from the recent U.S. tax reform.

                            Abaxis Well Poised on Solid Prospects, Competition Rife

                            Abaxis' (ABAX) new sales and marketing strategies boost investors' confidence.

                              New Strong Sell Stocks for December 7th

                              Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                                ABAXIS (ABAX) Up 6.7% Since Earnings Report: Can It Continue?

                                ABAXIS (ABAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                  Abaxis (ABAX) Posts In-Line Earnings in Q2, Lags Revenues

                                  Abaxis (ABAX) misses the Zacks Consensus Estimate for revenues due to softness in the medical market in Q2. Weak margins are a concern as well.

                                    New Strong Sell Stocks for September 11th

                                    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                                      New Strong Sell Stocks for August 21st

                                      Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday

                                        What Falling Estimates & Price Mean for Abaxis (ABAX)

                                        Abaxis (ABAX) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

                                          New Strong Sell Stocks for August 1st

                                          Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

                                            Abaxis (ABAX) Misses Earnings & Revenue Estimates in Q1

                                            Despite Abaxis' lackluster performance in the fiscal first quarter, its new marketing strategies and recent launches buoy optimism.

                                              Medical Product Stocks' Earnings on Jul 20: ABT, ISRG & More

                                              The market remained jittery towards medical space due to uncertainties surrounding the future of the healthcare act.

                                                Abaxis (ABAX) Product Portfolio Strong, Competition Rife

                                                On Jun 28, we issued an updated research report on California-based Abaxis, Inc. (ABAX).

                                                  New Strong Sell Stocks for May 2nd

                                                  Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: